Category:Anastasia Khvorova of Westborough MA (US)

Anastasia Khvorova of Westborough MA (US)

Executive Summary

Anastasia Khvorova of Westborough MA (US) is an inventor who has filed 9 patents. Their primary areas of innovation include Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants (5 patents), of the backbone (4 patents), 2'-O-R Modification (4 patents), and they have worked with companies such as UNIVERSITY OF MASSACHUSETTS (9 patents). Their most frequent collaborators include (2 collaborations), (2 collaborations), (2 collaborations).

Patent Filing Activity

Technology Areas

List of Technology Areas

• C12N15/113 (Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants): 5 patents
• C12N2310/315 (of the backbone): 4 patents
• C12N2310/321 (2'-O-R Modification): 4 patents
• C12N2310/14 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 3 patents
• C12N15/86 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 2 patents
• C12N2310/3515 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 2 patents
• C12N2310/312 (of the backbone): 2 patents
• C12N2310/11 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 2 patents
• C12N15/1137 ({against enzymes (viral enzymes): 1 patents
• A61K47/549 ({Sugars, nucleosides, nucleotides or nucleic acids}): 1 patents
• A61P27/02 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
• C12N2750/14122 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• C12N2750/14143 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• C12N15/85 (for animal cells): 1 patents
• C12N2310/351 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• C12N15/1135 ({against oncogenes or tumor suppressor genes}): 1 patents
• A61K9/0085 (Medicinal preparations characterised by special physical form {(nuclear magnetic resonance contrast preparations or magnetic resonance imaging contrast preparations): 1 patents
• A61P25/28 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
• C12N2310/52 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• C12N2320/30 (Special therapeutic applications): 1 patents
• C12N15/1138 ({against receptors or cell surface proteins}): 1 patents
• C12P21/00 (Preparation of peptides or proteins (single cell protein): 1 patents
• A61K47/554 ({the modifying agent being a steroid plant sterol, glycyrrhetic acid, enoxolone or bile acid}): 1 patents
• A61K9/0048 (Medicinal preparations characterised by special physical form {(nuclear magnetic resonance contrast preparations or magnetic resonance imaging contrast preparations): 1 patents
• A61K47/542 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• A61K47/543 ({Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine}): 1 patents
• A61K47/545 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• A61K47/548 ({Phosphates or phosphonates, e.g. bone-seeking (phospholipids): 1 patents
• C12N9/22 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• C12N15/907 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• C12N2310/20 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• C12N2310/531 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• C12N2800/80 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• A61P9/12 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
• A61K31/713 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• A61K31/203 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• A61K31/355 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• A61P43/00 (Drugs for specific purposes, not provided for in groups): 1 patents

Companies

List of Companies

• UNIVERSITY OF MASSACHUSETTS: 9 patents

Collaborators

• Claudio Punzo of Brookline MA (US) (2 collaborations)
• Dimas Echeverria Moreno of Worcester MA (US) (2 collaborations)
• Annabelle Biscans (2 collaborations)
• Julia F. Alterman of Westborough MA (US) (2 collaborations)
• Matthew Hassler of Boston MA (US) (2 collaborations)
• Shun-Yun Cheng of Westborough MA (US) (2 collaborations)
• Daniel O'Reilly (2 collaborations)
• Chantal Ferguson of Worcester MA (US) (2 collaborations)
• Jillian Belgrad of Worcester MA (US) (2 collaborations)
• Jillian Caiazzi of Boston MA (US) (1 collaborations)
• Julia Alterman of Worcester MA (US) (1 collaborations)
• Faith Conroy of Worcester MA (US) (1 collaborations)
• Edith Pfister of Boxborough MA (US) (1 collaborations)
• Neil Aronin of Newtonville MA (US) (1 collaborations)
• Ken Yamada of Boston MA (US) (1 collaborations)
• Bruno Miguel da Cruz Godinho of Worcester MA (US) (1 collaborations)
• James W. Gilbert of Worcester MA (US) (1 collaborations)
• Loïc Maurice René Jean Roux of Worcester MA (US) (1 collaborations)
• Ken Yamada of Westborough MA (US) (1 collaborations)
• Ken Yamada of Worcester MA (US) (1 collaborations)
• Erik Joseph Sontheimer of Auburndale MA (US) (1 collaborations)
• Vignesh Narayan Hariharan of Natick MA (US) (1 collaborations)
• Sarah Davis of Wellesley MA (US) (1 collaborations)
• Annabelle Biscans of Cambridge MA (US) (1 collaborations)
• Ananth Karumanchi of Chestnut Hill MA (US) (1 collaborations)